B

Researcher Profile

Beiying Ding

🏛 Amgen, Inc., Thousand Oaks, CA; USA

3

Publications

3,422

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article The Lancet Oncology Jul 01, 2021

Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial

Peter R Galle · Richard S Finn · Shukui Qin · Masafumi Ikeda +17 more

10.1016/s1470-2045(21)00151-0 325 citations

Journal Article New England Journal of Medicine Dec 06, 2018

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn · Aaron S. Mansfield · Aleksandra Szczęsna · Libor Havel +17 more

10.1056/nejmoa1809064 2,878 citations

Journal Article Journal of Bone and Mineral Research Jun 08, 2010

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Ian R Reid · Paul D Miller · Jacques P Brown · David L Kendler +11 more

10.1002/jbmr.149 219 citations

Publication Timeline

2021

1

2018

1

2010

1

Frequent Co-Authors

Aaron S. Mansfield

György Losonczy

Michael S Ominsky